Dr. Nicolaas Bohnen, MD

• Neurology

• Nuclear Medicine

*Healthgrades does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.

• The Role of Serotonin in Sleep Disordered Breathing Associated with Parkinson Disease: A Correlative [11C]DASB PET Imaging Study, 2012-07-05

• Cholinergic Denervation Patterns Across Cognitive Domains in Parkinson's Disease, 2020-11-02

• The cortical cholinergic system contributes to the top-down control of distraction: Evidence from patients with Parkinson's Disease, 2017-12-19

• Interactive effects of age and multi-gene profile on motor learning and sensorimotor adaptation, 2016-02-27

• Brain Dynamics Underlying Preserved Cycling Ability in Patients With Parkinson's Disease and Freezing of Gait, 2022-06-16

• Serotonin, beta-amyloid, and cognition in Parkinson disease, 2018-05-11

• Educational Attainment and Motor Burden in Parkinson disease, 2015-06-10

• Recent advances in cholinergic imaging and cognitive decline-Revisiting the cholinergic hypothesis of dementia, 2018-01-13

• Advances in Therapeutic Options for Gait and Balance in Parkinson's Disease, 2011-11-01

• Fatigue in Parkinson's Disease Associates with Lower Ambulatory Diastolic Blood Pressure, 2019-05-25

• Cholinergic brain network deficits associated with vestibular sensory conflict deficits in Parkinson's disease: correlation with postural and gait deficits, 2022-06-26

• Thalamic cholinergic innervation makes a specific bottom-up contribution to signal detection: Evidence from Parkinson's Disease patients with defined cholinergic losses, 2017-02-05

• Molecular Imaging of the Cholinergic system in Parkinson's disease, 2018-09-20

• An Updated Diagnostic Approach to Subtype Definition of Vascular Parkinsonism - Recommendations from an expert working group, 2017-12-29

• Ketogenic-Mimicking Diet as a Therapeutic Modality for Bipolar Disorder: Biomechanistic Rationale and Protocol for a Pilot Clinical Trial, 2023-07-07

• Mentally stimulating activities associate with better cognitive performance in Parkinson disease, 2017-07-19

• Dopaminergic Polymorphisms Associated with Medication Responsiveness of Gait in Parkinson's Disease, 2017-12-12

• Extra-nigral pathologies are common in Parkinson disease with freezing of gait: anin vivoPET study, 2014-06-07

• Imaging: what can it tell us about parkinsonian gait?, 2013-09-15

• Gender Differences in Cholinergic and Dopaminergic Deficits in Parkinson Disease, 2013-03-27

• Cerebral Glucose Metabolic Features of Parkinson Disease and Incident Dementia: Longitudinal Study, 2011-05-13

• Source memory and frontal functioning in Parkinson's disease, 2009-06-15

• Regional cerebral cholinergic nerve terminal integrity and cardinal motor features in Parkinson's disease, 2021-05-22

• Abnormal MoCA and Normal Range MMSE scores in Parkinson disease without dementia: Cognitive and Neurochemical Correlates, 2014-07-19

• Age-associated striatal dopaminergic denervation and falls in community-dwelling subjects, 2016-05-21

• Multimodal Dopaminergic and Free-Water Imaging in Parkinson's Disease, 2019-01-06

• In VivoNeurochemical Imaging of Olfactory Dysfunction in Parkinson's Disease, 2012-12-21

• Diabetes mellitus is independently associated with more severe cognitive impairment in Parkinson disease, 2014-10-15

• Altered cerebellar connectivity in Parkinson's patients ON and OFF L-DOPA medication, 2015-04-21

• ß-amyloid and postural instability and gait difficulty in Parkinson disease at risk for dementia, 2012-12-12

• Cholinergic Dysfunction in Parkinson's Disease, 2013-09-27

• Rhinorrhea: A common non-dopaminergic feature of Parkinson disease, 2010-09-14

• Thalamic cholinergic innervation is spared in Alzheimer disease compared to Parkinsonian disorders, 2012-03-03

• Catechol-O-methyltransferase (COMT) polymorphism predicts rapid gait speed changes in healthy older adults, 2021-07-06

• Targeting the Pedunculopontine Nucleus in Parkinson's disease: Time to Go Back to the Drawing Board, 2018-11-06

• The Pattern of Striatal Dopaminergic Denervation Explains Sensorimotor Synchronization Accuracy in Parkinson's Disease, 2013-09-25

• Association of Cardinal Motor Symptoms with Region-Specific Dopamine Transporter Activity in Mild to Moderate Parkinson's Disease, 2017-09-16

• Quantification of brain cholinergic denervation in dementia with Lewy bodies using PET imaging with [18F]-FEOBV, 2018-08-06

• Diabetes is associated with Postural Instability and Gait Difficulty in Parkinson disease, 2013-02-23

• Symptoms of Rapid Eye Movement Sleep Behavior Disorder are Associated with Cholinergic Denervation in Parkinson Disease, 2013-07-02

• New Developments in Cholinergic Imaging in Alzheimer and Lewy Body Disorders, 2020-10-09

• Risky driving and pedunculopontine nucleus-thalamic cholinergic denervation in Parkinson Disease, 2013-09-08

• The contribution of cerebrovascular risk factors, metabolic and inflammatory changes to cognitive decline in Parkinson's disease, 2019-07-22

• Decreased Vestibular Efficacy Contributes to Abnormal Balance in Parkinson's Disease, 2022-07-28

• Topography of Cholinergic Changes in Dementia with Lewy Bodies Involves Key Neural Network Hubs, 2020-06-05

• Vestibular sensory conflict during postural control, freezing of gait and falls in Parkinson's disease, 2022-08-15

• Cerebral topography of vesicular cholinergic transporter changes in neurologically intact adults: A [18F]FEOBV PET study, 2022-03-28

• Cholinergic system changes of falls and freezing of gait in Parkinson disease, 2019-03-13

• Color discrimination errors associate with axial motor impairments in Parkinson's disease, 2017-09-08

• Effects of plasma glucose levels on regional cerebral 18F-fluorodeoxyglucose uptake: Implications for dementia evaluation with brain PET imaging, 2019-02-20

• a4ß2* Nicotinic Cholinergic Receptor Target Engagement in Parkinson Disease Gait-Balance Disorders, 2021-05-26

• Neuroimaging and clinical predictors of fatigue in Parkinson disease, 2015-12-02

• Frequency of cholinergic and caudate nucleus dopaminergic deficits across pre-demented cognitive spectrum of Parkinson disease and evidence of interaction effects, 2017-08-01

• No Dopamine Agonist Modulation of Brain [18F]FEOBV Binding in Parkinson's Disease, 2022-03-15

• Differential cholinergic systems changes in progressive supranuclear palsy versus Parkinson's disease: an exploratory analysis, 2022-10-12

• Appropriate Use Criteria for Amyloid PET A Report of the Amyloid Imaging Task Force (AIT), the Society of Nuclear Medicine and Molecular Imaging (SNMMI) and the Alzheimer Association (AA), 2013-06-28

• Association between autonomic dysfunction and fatigue in Parkinson disease, 2017-04-17

• Molecular Imaging of the Cholinergic System in Alzheimer and Lewy body Dementias: Expanding Views, 2021-09-20

• Development and Validation of the Automated Imaging Differentiation in Parkinsonism (AID-P): A Multi-Site Machine Learning Study, 2019-08-27

• Clinical Markers for Identifying Cholinergic Deficits in Parkinson's Disease, 2014-11-12

• Striatal and cortical ß-amyloidopathy and cognition in Parkinson disease, 2015-09-18

• Motor Speech Apraxia in a 70-Year-Old Man with Left Dorsolateral Frontal Arachnoid Cyst: A [18F]FDG PET-CT Study, 2016-11-24

• PERIPHERAL NEUROPATHY IS ASSOCIATED WITH MORE FREQUENT FALLS IN PARKINSON'S DISEASE, 2018-04-03

• Subtype definition of vascular parkinsonism, 2018-03-09

• Cortico-striatal functional connectivity and cerebral small vessel disease: Contribution to mild Parkinsonian signs, 2021-12-27

• Regional Vesicular Acetylcholine Transporter Distribution in Human Brain: A [18F]Fluoroethoxybenzovesamicol Positron Emission Tomography Study, 2018-10-19

• Orthostatic hypotension predicts motor decline in early Parkinson disease, 2016-09-09

• Compensatory dopaminergic-cholinergic interactions in conflict processing: Evidence from patients with Parkinson's Disease, 2018-01-11

• Cerebral amyloid burden and Hoehn and Yahr stage 3 scoring in Parkinson disease, 2017-04-08

• Dopamine overdose hypothesis: Evidence and clinical implications, 2013-10-09

• Amyloid deposition in Parkinson Disease and Cognitive Impairment: A Systematic Review, 2015-04-16

• Cholinergic systems, attentional-motor integration, and cognitive control in Parkinson's disease, 2022-02-04

• Model-based and Model-free Machine Learning Techniques for Diagnostic Prediction and Classification of Clinical Outcomes in Parkinson's Disease, 2018-05-08

• Ketogenic interventions in mild cognitive impairment, Alzheimer's disease, and Parkinson's disease: A systematic review and critical appraisal, 2023-02-09

• Feasibility and behavioral effects of prolonged static and dynamic standing as compared to sitting in older adults with type 2 diabetes mellitus, 2020-06-11

• Predicting first fall in newly diagnosed Parkinson's disease: Insights from a fall-naive cohort, 2016-09-13

• Parkinson's Disease: What role do pedunculopontine nucleus cholinergic neurons play?, 2013-12-16

• Prevalence of Impaired Odor Identification in Parkinson Disease with Imaging Evidence of Nigrostriatal Denervation, 2016-02-24

• Non-exercise physical activity attenuates motor symptoms in Parkinson disease independent from nigrostriatal degeneration, 2015-08-28

• Cardiovascular Risk Factor Burden in Veterans and Non-Veterans with Parkinson Disease, 2018-03-22

• TWO AUTOCOVARIANCE-BASED MEASURES OF BALANCE IN PARKINSONIANS AND NORMAL CONTROLS, 2017-08-03

• Identification of cholinergic centro-cingulate topography as main contributor to cognitive functioning in Parkinson's disease: Results from a data-driven approach, 2022-10-20